Early Christmas present!👇 A few months ago, @adflegal worked with investors to send letters to @Costco, @Walmart, @kroger, @Albertsons, and @McKesson, calling them to not offer mifepristone, a drug used in over half of all abortions in the U.S. This was in response to @NYCComptroller calling on retailers to sell mifepristone and falsely saying it was as safe as ibuprofen. As we argued at SCOTUS, the FDA’s own label admits that roughly one in 25 women who take this drug will end up in the ER. On Wednesday, @SamsClub, a division of Walmart, and Kroger confirmed that they are NOT selling Mifepristone on their websites or at their stores. The letters we sent to Walmart and Kroger included investors, investment advisors, fiduciaries, proxy voting and corporate engagement consultants to investors who hold over $100 billion in total assets under management and $92 million in stock at Walmart and Kroger. The letters’ message was clear, they said: “Dispensing [Mifepristone] is filled with legal and political risk and will inject [Walmart/Kroger] into the middle of an intense political battle at great expense to its reputation. It is also wholly unnecessary to your business. We urge you not to dispense mifepristone.” We are delighted that these companies are making the right decision. Retail pharmacies should prioritize the health of their customers, and not bow to political pressure that puts women in harm's way. We hope to see other retailers follow suit and take this harmful drug off the shelves for good. We will continue to work with shareholders to monitor these companies’ behavior and hold them accountable. Thank you @inspireadvisor, @DavidBahnsen, @JerryLeeBowyer, and @GuideStone for helping to make this happen.